Melissa S. DeRycke - Concepedia

Author

Melissa S. DeRycke

Also Known As

Darshana Daftary, M Derycke, M. Derycke, Martine Derycke, Melissa S. DeRycke, Melissa DeRycke, Melissa S DeRycke, Melissa S. DeRycke, Wang, Zhong

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Fred Hutch Cancer Center Mayo Clinic in Arizona Mayo Clinic Mayo Clinic in Florida University of Southern California

About

Melissa S. DeRycke is an author at Fred Hutch Cancer Center specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	462
2	Immunology	3	3	97
3	Public Health	2	2	72
4	Health Sciences	1	1	52
5	Cell Biology	1	1	22

Melissa S. DeRycke

Publications

876

Citations

H-Index

Page 1

	Year	Citations
Nectin 4 Overexpression in Ovarian Cancer Tissues and Serum Melissa S. DeRycke, Stefan E. Pambuccian, C. Blake Gilks, American Journal of Clinical Pathology Tumor BiologyOncologyNectin 4Quantitative Rt-pcrMedicine	2010	257
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG) Jianfeng Xu, Ethan M. Lange, Lingyi Lu, Human Genetics	2012	194
S100A1 Expression in Ovarian and Endometrial Endometrioid Carcinomas Is a Prognostic Indicator of Relapse-Free Survival Melissa S. DeRycke, John D. Andersen, Katherine M. Harrington, American Journal of Clinical Pathology S100a1 ExpressionMalignant DiseaseMedicineRelapse-free SurvivalGynecology	2009	58
Intravenous immunoglobulin for neonatal isoimmune thrombocytopenia. Melissa S. DeRycke, Marie Dreyfus, J C Ropert, Archives of Disease in Childhood ImmunohematologyIntravenous ImmunoglobulinImmunologyImmunotherapyIntravenous Gammaglobulin	1985	52
Characterization of the blast cell population in two neonates with Down's syndrome and transient myeloproliferative disorder Laure Coulombel, Melissa S. DeRycke, Jean‐Luc Villeval, British Journal of Haematology Mixed-phenotype Acute LeukemiaPathologyTransient Myeloproliferative DisorderDefectsMyeloid Neoplasia	1987	50
Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes Melissa S. DeRycke, Shanaka R. Gunawardena, Jessica R. Balcom, Molecular Genetics & Genomic Medicine	2017	44
Germline mutations in<i>PMS2</i>and<i>MLH1</i>in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort Christophe Rosty, Mark Clendenning, Michael D. Walsh, BMJ Open	2016	41
Identification of Novel Variants in Colorectal Cancer Families by High-Throughput Exome Sequencing Melissa S. DeRycke, Shanaka R. Gunawardena, Sumit Middha, Cancer Epidemiology Biomarkers & Prevention	2013	40
Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation Kristin L.M. Boylan, Benjamin S Misemer, Melissa S. DeRycke, International Journal of Molecular Sciences	2011	40
Early detection of ovarian cancer using group biomarkers Alain Tchagang, Ahmed H. Tewfik, Melissa S. DeRycke, Molecular Cancer Therapeutics	2008	33

Page 1